Target intelligence / Profile preview

Protein bicaudal D homolog 2 (BICD2)

Target
BICD2
Molecular classification
Cargo adaptor protein, Coiled-coil protein, Dynein adaptor
01

Overview

Protein bicaudal D homolog 2 (BICD2) is a conserved coiled-coil cargo adaptor protein involved in intracellular transport. It functions primarily by binding and activating the dynein-dynactin motor complex, facilitating minus-end-directed transport along microtubules. BICD2 couples dynein to a variety of cargos—including Golgi-derived vesicles and synaptic vesicles—by interacting via its C-terminal domain with cargo proteins such as the GTPase Rab6. In neurons, BICD2 is crucial for the proper transport of synaptic vesicles. Mutations in BICD2 are associated with autosomal dominant spinal muscular atrophy with lower extremity predominance (SMA-LED), manifesting as lower limb muscle weakness and atrophy[4][1][2][3]. BICD2 is not a typical pharmacological target such as an enzyme or receptor, and no known drugs currently act directly on this protein.

Other names
BICD2BICD cargo adaptor 2KIAA0699Bic-D 2SMALED2SMALED2ASMALED2BbA526D8.1coiled-coil protein BICD2cytoskeleton-like bicaudal D protein homolog 2homolog of Drosophila bicaudal D
02

Biological functions

Intracellular transportOrganelle positioningCytoskeleton organizationVesicle traffickingSynaptic vesicle transport (in neurons)
03

Disease associations

Neurodegenerative disease (linked to spinal muscular atrophy with lower extremity predominance; SMA-LED)Other (impaired intracellular transport disorders)
04

Safety considerations

Mutations cause autosomal dominant neuromuscular disease (SMA-LED) with lower limb muscle weakness and atrophy[4]

Beyond the preview

Go deeper on Protein bicaudal D homolog 2 (BICD2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein bicaudal D homolog 2 (BICD2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call